Literature DB >> 33630149

[Acute unilateral loss of vision after intravitreal injection of a VEGF inhibitor].

N Kaupke1, N Stübiger2, S Dulz2, M S Spitzer2, M Casagrande2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33630149     DOI： 10.1007/s00347-021-01343-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  3 in total

1.  Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis.

Authors:  Andre J Witkin; Paul Hahn; Timothy G Murray; J Fernando Arevalo; Kevin J Blinder; Netan Choudhry; Geoff G Emerson; Roger A Goldberg; Stephen J Kim; Joel Pearlman; Eric W Schneider; Homayoun Tabandeh; Robert W Wong
Journal:  J Vitreoretin Dis       Date:  2020-12-15

2.  Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.

Authors:  Glenn J Jaffe; Usha Chakravarthy; K Bailey Freund; Robyn H Guymer; Frank G Holz; Sandra Liakopoulos; Jordi M Monés; Philip J Rosenfeld; Srinivas R Sadda; David Sarraf; Steffen Schmitz-Valckenberg; Richard F Spaide; Giovanni Staurenghi; Adnan Tufail; Christine A Curcio
Journal:  Ophthalmol Retina       Date:  2020-12-22

Review 3.  Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.

Authors:  Caroline R Baumal; Bahram Bodaghi; Michael Singer; David J Tanzer; András Seres; Mayur R Joshi; Nicolas Feltgen; Richard Gale
Journal:  Ophthalmol Retina       Date:  2020-09-29
  3 in total
  1 in total

Review 1.  A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment.

Authors:  Frank G Holz; Tomohiro Iida; Ichiro Maruko; SriniVas R Sadda
Journal:  Retina       Date:  2022-06-13       Impact factor: 3.975
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.